Patent · US Active

Process for purifying interferon beta

US7780960B2 · kind B2 · utility

1Cited by
13References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2004
Grant dateAug 24, 2010
Priority date
Expiry dateSep 3, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/06139
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided is a process for purifying human interferon beta from a recombinant human interferon beta-containing culture comprising performing affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC), wherein the affinity chromatography includes: adsorbing the interferon beta-containing culture to an equilibrated affinity chromatography column, followed by washing with an equilibration buffer solution; washing the column with a washing buffer solution A of pH 6.5-7.5 containing 30-60 wt % of propylene glycol and a washing buffer solution B of pH 6.5-7.5 containing 10-30 wt % of propylene glycol and 1-2M NaCl; and eluting a human interferon beta-containing fraction with a buffer solution of pH 6.5-7.5 containing 40-60 wt % of propylene glycol and 1-2M NaCl.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.